Figure 5

Distribution of PIK3CA mutational status in patients’ tumors across nodal status in the primary setting. Distribution of PIK3CA mutational status in primary tumors by pN category (a) and nodal status (b) of the primary tumor. Distribution of mutational status of relapse tumors by pN category (c) and nodal status (d) of the primary tumor.